Andrew Craig Miller
Net Worth

Last updated:

What is Andrew Craig Miller net worth?

The estimated net worth of Dr. Andrew Craig Miller is at least $29,986,112 as of 20 Apr 2023. He has earned $26,753,362 from insider trading and has received compensation worth at least $3,232,750 in Karuna Therapeutics, Inc..

What is the salary of Andrew Craig Miller?

Dr. Andrew Craig Miller salary is $646,550 per year as Co-Founder & Chief Operating Officer in Karuna Therapeutics, Inc..

How old is Andrew Craig Miller?

Dr. Andrew Craig Miller is 43 years old, born in 1982.

What stocks does Andrew Craig Miller currently own?

As insider, Dr. Andrew Craig Miller owns shares in one company:

Company Title Shares Price per share Total value
Karuna Therapeutics, Inc. (KRTX) Co-Founder & Chief Operating Officer 24,400 $0 $0

What does Karuna Therapeutics, Inc. do?

Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients with schizophrenia; and for the treatment of central nervous system disorders, such as negative and cognitive symptoms of schizophrenia and psychosis, as well as for the treatment of dementia-related psychosis. The company also focuses on developing other muscarinic-targeted drug candidates. Karuna Therapeutics, Inc. has a license agreement with Eli Lilly and Company, and Zai Lab (Shanghai) Co., Ltd; patent license agreement with PureTech Health LLC; and drug discovery partnership with Charles River Laboratories, as well as drug discovery collaboration with PsychoGenics, Inc. The company was formerly known as Karuna Pharmaceuticals, Inc. and changed its name to Karuna Therapeutics, Inc. in March 2019. Karuna Therapeutics, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.

KRTX logo
KRTX
Karuna Therapeutics, Inc.

Andrew Craig Miller insider trading

Karuna Therapeutics, Inc.

Dr. Andrew Craig Miller has made 32 insider trades between 2020-2023, according to the Form 4 filled with the SEC. Most recently he sold 15,000 units of KRTX stock worth $3,001,950 on 20 Apr 2023.

The largest trade he's ever made was exercising 41,333 units of KRTX stock on 15 Jun 2020. As of 20 Apr 2023 he still owns at least 24,400 units of KRTX stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 15,000 $200.13 $3,001,950
Option
Common Stock 8,500 $9.2 $78,200
Option
Option (right to buy) 8,500 $9.2 $78,200
Sale
Common Stock 30,000 $200.16 $6,004,800
Option
Option (right to buy) 30,000 $9.2 $276,000
Option
Common Stock 30,000 $9.2 $276,000
Option
Common Stock 7,100 $2.92 $20,732
Option
Option (right to buy) 7,100 $2.92 $20,732
Option
Common Stock 250 $7.27 $1,818
Option
Option (right to buy) 250 $7.27 $1,818
Option
Option (right to buy) 500 $2.92 $1,460
Option
Common Stock 500 $2.92 $1,460
Sale
Common Stock 15,000 $228.3 $3,424,500
Option
Common Stock 1,000 $2.92 $2,920
Option
Option (right to buy) 1,000 $7.27 $7,270
Option
Common Stock 1,000 $7.27 $7,270
Option
Option (right to buy) 1,000 $2.92 $2,920
Sale
Common Stock 15,000 $225.98 $3,389,700
Option
Common Stock 2,000 $2.92 $5,840
Option
Option (right to buy) 2,000 $2.92 $5,840
Sale
Common Stock 15,000 $225.08 $3,376,200
Option
Common Stock 26,500 $2.92 $77,380
Option
Option (right to buy) 26,500 $2.92 $77,380
Sale
Common Stock 2,827 $141.29 $399,427
Sale
Common Stock 3,029 $125.17 $379,140
Sale
Common Stock 13,471 $122.08 $1,644,499
Sale
Common Stock 2,673 $125.51 $335,488
Sale
Common Stock 5,500 $118.67 $652,685
Option
Option (right to buy) 12,500 $2.92 $36,500
Option
Common Stock 12,500 $2.92 $36,500
Sale
Common Stock 5,500 $104.37 $574,052
Option
Common Stock 8,334 $131.44 $1,095,421
Sale
Common Stock 8,334 $131.44 $1,095,421
Option
Option (right to buy) 8,334 $131.44 $1,095,421
Option
Option (right to buy) 8,333 $129.33 $1,077,707
Sale
Common Stock 8,333 $129.33 $1,077,707
Option
Common Stock 8,333 $129.33 $1,077,707
Sale
Common Stock 13,333 $9.2 $122,664
Option
Option (right to buy) 13,333 $9.2 $122,664
Option
Common Stock 13,333 $9.2 $122,664
Option
Option (right to buy) 5,000 N/A N/A
Option
Common Stock 5,000 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 5,000 $9.2 $46,000
Option
Option (right to buy) 5,000 $9.2 $46,000
Option
Common Stock 5,000 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Option
Common Stock 5,000 N/A N/A
Option
Option (right to buy) 5,000 $9.2 $46,000
Option
Option (right to buy) 5,000 N/A N/A
Option
Common Stock 5,000 $9.2 $46,000
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 3,572 $7.27 $25,968
Option
Common Stock 5,000 $3.64 $18,175
Option
Common Stock 5,000 $52.56 $262,775
Option
Option (right to buy) 5,000 $56.19 $280,950
Option
Option (right to buy) 5,000 N/A N/A
Option
Common Stock 12,500 $2.92 $36,500
Option
Option (right to buy) 12,500 $2.92 $36,500
Option
Common Stock 5,000 $94.82 $474,100
Option
Option (right to buy) 5,000 $94.82 $474,100
Sale
Common Stock 3,571 $94.82 $338,602
Option
Common Stock 5,000 $94.82 $474,100
Option
Option (right to buy) 5,000 $47.41 $237,050
Option
Common Stock 8,334 N/A N/A
Sale
Common Stock 8,334 $100 $833,400
Option
Option (right to buy) 8,334 $100 $833,400
Option
Common Stock 8,333 $100.01 $833,383
Sale
Common Stock 8,333 N/A N/A
Option
Option (right to buy) 8,333 $100.01 $833,383
Sale
Common Stock 4,286 $7.27 $31,159
Option
Option (right to buy) 13,333 $55.54 $740,448
Option
Common Stock 13,333 $55.54 $740,448
Sale
Common Stock 5,000 N/A N/A
Option
Option (right to buy) 5,000 N/A N/A
Option
Common Stock 5,000 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Option
Common Stock 5,000 N/A N/A
Option
Option (right to buy) 5,000 N/A N/A
Option
Common Stock 8,334 N/A N/A
Option
Option (right to buy) 8,334 N/A N/A
Sale
Common Stock 8,334 N/A N/A
Option
Option (right to buy) 41,333 $62.56 $2,585,792
Option
Common Stock 41,333 N/A N/A
Option
Common Stock 41,333 $62.56 $2,585,792
Sale
Common Stock 3,571 N/A N/A
Option
Option (right to buy) 41,333 N/A N/A
Sale
Common Stock 4,968 N/A N/A
Option
Option (right to buy) 8,333 N/A N/A
Option
Common Stock 8,333 N/A N/A
Option
Option (right to buy) 25,000 N/A N/A
Option
Common Stock 25,000 N/A N/A
Sale
Common Stock 25,000 N/A N/A
Option
Option (right to buy) 25,000 N/A N/A
Sale
Common Stock 25,000 N/A N/A
Option
Common Stock 25,000 N/A N/A
Option
Common Stock 25,000 N/A N/A
Option
Option (right to buy) 25,000 N/A N/A
Sale
Common Stock 10,654 N/A N/A
Option
Option (right to buy) 25,000 $33.65 $841,125
Option
Common Stock 25,000 N/A N/A
Sale
Common Stock 17,857 N/A N/A
Option
Option (right to buy) 25,000 N/A N/A
Option
Option (right to buy) 25,000 $44.77 $1,119,125

Karuna Therapeutics key executives

Karuna Therapeutics, Inc. executives and other stock owners filed with the SEC: